THURSDAY, Dec. 12, 2019 -- Nearly six years after stopping a five-year regimen of the breast cancer drug anastrozole, women at high risk for breast cancer were 50% less likely to have been struck by the disease, new research shows.
The trial included more than 3,800 postmenopausal women at high risk for breast cancer. They were deemed to be at high risk for a variety of reasons, including having two or more blood relatives with breast cancer, having a mother or sister who developed breast cancer before age 50, and having a mother or sister who had breast cancer in both breasts.
FRIDAY, Dec. 13, 2019 -- The ongoing debate about postmenopausal hormone therapy and breast cancer risk may have turned even more muddy: A large, new study suggests that two different types of hormone therapy have opposite effects on women's long-term risk of the disease.
The researchers found that combined hormone replacement therapy (HRT) -- with estrogen and progestin -- increases the risk of breast cancer, with effects that last for years after women discontinue the therapy.
WEDNESDAY, Nov. 20, 2019 -- It's not uncommon for a woman's sex life to slow down with age, but hormones aren't the only reason she might not be in the mood, a new study suggests.
Postmenopausal issues, such as vaginal dryness or pain during sex, definitely put a damper on a woman's desire. But just as often, it was issues with her partner that brought sexual activity to a halt.